avutometinib
verastem
['avutometinib', 'verastem']
we are pleased to share updates at #aacr2023 across our raf/mek clamp avutometinib clinical trial program, including data from combination studies with anti-egfr and anti-pd1 inhibitors targeting difficult-to-treat ras pathway-driven cancers. 
Verastem Oncology is a biopharma company that develops medicines to improve survival and quality of life of #cancer patients. $VSTM